1. Home
  2. Pharma & Healthcare
  3. Global Live Cell Imaging Market 2020 by Company, Regions, Type and Application, Forecast to 2025

Global Live Cell Imaging Market 2020 by Company, Regions, Type and Application, Forecast to 2025

Publication Month: Jan 2020 | No. of Pages: 100 Published By: Global Info Research
Single User License: US $ 3480
Corporate User License: US $ 6960

Market Overview
The global Live Cell Imaging market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 6.8% in the forecast period of 2020 to 2025 and will expected to reach USD 2035.9 million by 2025, from USD 1564 million in 2019.

The Live Cell Imaging market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation
Live Cell Imaging market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Live Cell Imaging market has been segmented into:
Equipment
Consumables
Software

By Application, Live Cell Imaging has been segmented into:
Hospitals
Pharmaceutical Companies
Biotechnological Companies
Diagnostic Laboratories
Others

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Live Cell Imaging market presented in the report. This section sheds light on the sales growth of different regional and country-level Live Cell Imaging markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Live Cell Imaging market.

The report offers in-depth assessment of the growth and other aspects of the Live Cell Imaging market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Competitive Landscape and Live Cell Imaging Market Share Analysis
Live Cell Imaging competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Live Cell Imaging sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Live Cell Imaging sales, revenue and market share for each player covered in this report.

The major players covered in Live Cell Imaging are:
Carl Zeiss (Germany)
Sigma-Aldrich (U.S.)
GE Healthcare (U.K.)
Leica Microsystems (Germany)
Danaher (U.S.)
Olympus (Japan)
Molecular Devices (U.S.)
Thermo Fisher Scientific (U.S.)
BD (U.S.)
Nikon (Japan)
PerkinElmer (U.S.)
BioTek Instruments (U.S.)

Table of Contents

1 Live Cell Imaging Market Overview
1.1 Product Overview and Scope of Live Cell Imaging
1.2 Classification of Live Cell Imaging by Type
1.2.1 Global Live Cell Imaging Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Live Cell Imaging Revenue Market Share by Type in 2019
1.2.3 Equipment
1.2.4 Consumables
1.2.5 Software
1.3 Global Live Cell Imaging Market by Application
1.3.1 Overview: Global Live Cell Imaging Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospitals
1.3.3 Pharmaceutical Companies
1.3.4 Biotechnological Companies
1.3.5 Diagnostic Laboratories
1.3.6 Others
1.4 Global Live Cell Imaging Market by Regions
1.4.1 Global Live Cell Imaging Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Live Cell Imaging (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Live Cell Imaging Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Live Cell Imaging Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Live Cell Imaging Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Live Cell Imaging Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Live Cell Imaging Status and Prospect (2015-2025)
2 Company Profiles
2.1 Carl Zeiss (Germany)
2.1.1 Carl Zeiss (Germany) Details
2.1.2 Carl Zeiss (Germany) Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Carl Zeiss (Germany) SWOT Analysis
2.1.4 Carl Zeiss (Germany) Product and Services
2.1.5 Carl Zeiss (Germany) Live Cell Imaging Revenue, Gross Margin and Market Share (2018-2019)
2.2 Sigma-Aldrich (U.S.)
2.2.1 Sigma-Aldrich (U.S.) Details
2.2.2 Sigma-Aldrich (U.S.) Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Sigma-Aldrich (U.S.) SWOT Analysis
2.2.4 Sigma-Aldrich (U.S.) Product and Services
2.2.5 Sigma-Aldrich (U.S.) Live Cell Imaging Revenue, Gross Margin and Market Share (2018-2019)
2.3 GE Healthcare (U.K.)
2.3.1 GE Healthcare (U.K.) Details
2.3.2 GE Healthcare (U.K.) Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 GE Healthcare (U.K.) SWOT Analysis
2.3.4 GE Healthcare (U.K.) Product and Services
2.3.5 GE Healthcare (U.K.) Live Cell Imaging Revenue, Gross Margin and Market Share (2018-2019)
2.4 Leica Microsystems (Germany)
2.4.1 Leica Microsystems (Germany) Details
2.4.2 Leica Microsystems (Germany) Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Leica Microsystems (Germany) SWOT Analysis
2.4.4 Leica Microsystems (Germany) Product and Services
2.4.5 Leica Microsystems (Germany) Live Cell Imaging Revenue, Gross Margin and Market Share (2018-2019)
2.5 Danaher (U.S.)
2.5.1 Danaher (U.S.) Details
2.5.2 Danaher (U.S.) Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Danaher (U.S.) SWOT Analysis
2.5.4 Danaher (U.S.) Product and Services
2.5.5 Danaher (U.S.) Live Cell Imaging Revenue, Gross Margin and Market Share (2018-2019)
2.6 Olympus (Japan)
2.6.1 Olympus (Japan) Details
2.6.2 Olympus (Japan) Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Olympus (Japan) SWOT Analysis
2.6.4 Olympus (Japan) Product and Services
2.6.5 Olympus (Japan) Live Cell Imaging Revenue, Gross Margin and Market Share (2018-2019)
2.7 Molecular Devices (U.S.)
2.7.1 Molecular Devices (U.S.) Details
2.7.2 Molecular Devices (U.S.) Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Molecular Devices (U.S.) SWOT Analysis
2.7.4 Molecular Devices (U.S.) Product and Services
2.7.5 Molecular Devices (U.S.) Live Cell Imaging Revenue, Gross Margin and Market Share (2018-2019)
2.8 Thermo Fisher Scientific (U.S.)
2.8.1 Thermo Fisher Scientific (U.S.) Details
2.8.2 Thermo Fisher Scientific (U.S.) Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Thermo Fisher Scientific (U.S.) SWOT Analysis
2.8.4 Thermo Fisher Scientific (U.S.) Product and Services
2.8.5 Thermo Fisher Scientific (U.S.) Live Cell Imaging Revenue, Gross Margin and Market Share (2018-2019)
2.9 BD (U.S.)
2.9.1 BD (U.S.) Details
2.9.2 BD (U.S.) Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 BD (U.S.) SWOT Analysis
2.9.4 BD (U.S.) Product and Services
2.9.5 BD (U.S.) Live Cell Imaging Revenue, Gross Margin and Market Share (2018-2019)
2.10 Nikon (Japan)
2.10.1 Nikon (Japan) Details
2.10.2 Nikon (Japan) Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Nikon (Japan) SWOT Analysis
2.10.4 Nikon (Japan) Product and Services
2.10.5 Nikon (Japan) Live Cell Imaging Revenue, Gross Margin and Market Share (2018-2019)
2.11 PerkinElmer (U.S.)
2.11.1 PerkinElmer (U.S.) Details
2.11.2 PerkinElmer (U.S.) Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 PerkinElmer (U.S.) SWOT Analysis
2.11.4 PerkinElmer (U.S.) Product and Services
2.11.5 PerkinElmer (U.S.) Live Cell Imaging Revenue, Gross Margin and Market Share (2018-2019)
2.12 BioTek Instruments (U.S.)
2.12.1 BioTek Instruments (U.S.) Details
2.12.2 BioTek Instruments (U.S.) Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 BioTek Instruments (U.S.) SWOT Analysis
2.12.4 BioTek Instruments (U.S.) Product and Services
2.12.5 BioTek Instruments (U.S.) Live Cell Imaging Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Live Cell Imaging Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Live Cell Imaging Players Market Share
3.2.2 Top 10 Live Cell Imaging Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Live Cell Imaging Revenue and Market Share by Regions
4.2 North America Live Cell Imaging Revenue and Growth Rate (2015-2020)
4.3 Europe Live Cell Imaging Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Live Cell Imaging Revenue and Growth Rate (2015-2020)
4.5 South America Live Cell Imaging Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Live Cell Imaging Revenue and Growth Rate (2015-2020)
5 North America Live Cell Imaging Revenue by Countries
5.1 North America Live Cell Imaging Revenue by Countries (2015-2020)
5.2 USA Live Cell Imaging Revenue and Growth Rate (2015-2020)
5.3 Canada Live Cell Imaging Revenue and Growth Rate (2015-2020)
5.4 Mexico Live Cell Imaging Revenue and Growth Rate (2015-2020)
6 Europe Live Cell Imaging Revenue by Countries
6.1 Europe Live Cell Imaging Revenue by Countries (2015-2020)
6.2 Germany Live Cell Imaging Revenue and Growth Rate (2015-2020)
6.3 UK Live Cell Imaging Revenue and Growth Rate (2015-2020)
6.4 France Live Cell Imaging Revenue and Growth Rate (2015-2020)
6.5 Russia Live Cell Imaging Revenue and Growth Rate (2015-2020)
6.6 Italy Live Cell Imaging Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Live Cell Imaging Revenue by Countries
7.1 Asia-Pacific Live Cell Imaging Revenue by Countries (2015-2020)
7.2 China Live Cell Imaging Revenue and Growth Rate (2015-2020)
7.3 Japan Live Cell Imaging Revenue and Growth Rate (2015-2020)
7.4 Korea Live Cell Imaging Revenue and Growth Rate (2015-2020)
7.5 India Live Cell Imaging Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Live Cell Imaging Revenue and Growth Rate (2015-2020)
8 South America Live Cell Imaging Revenue by Countries
8.1 South America Live Cell Imaging Revenue by Countries (2015-2020)
8.2 Brazil Live Cell Imaging Revenue and Growth Rate (2015-2020)
8.3 Argentina Live Cell Imaging Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Live Cell Imaging by Countries
9.1 Middle East & Africa Live Cell Imaging Revenue by Countries (2015-2020)
9.2 Saudi Arabia Live Cell Imaging Revenue and Growth Rate (2015-2020)
9.3 UAE Live Cell Imaging Revenue and Growth Rate (2015-2020)
9.4 Egypt Live Cell Imaging Revenue and Growth Rate (2015-2020)
9.5 South Africa Live Cell Imaging Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Live Cell Imaging Revenue and Market Share by Type (2015-2020)
10.2 Global Live Cell Imaging Market Forecast by Type (2019-2024)
10.3 Equipment Revenue Growth Rate (2015-2025)
10.4 Consumables Revenue Growth Rate (2015-2025)
10.5 Software Revenue Growth Rate (2015-2025)
11 Global Live Cell Imaging Market Segment by Application
11.1 Global Live Cell Imaging Revenue Market Share by Application (2015-2020)
11.2 Live Cell Imaging Market Forecast by Application (2019-2024)
11.3 Hospitals Revenue Growth (2015-2020)
11.4 Pharmaceutical Companies Revenue Growth (2015-2020)
11.5 Biotechnological Companies Revenue Growth (2015-2020)
11.6 Diagnostic Laboratories Revenue Growth (2015-2020)
11.7 Others Revenue Growth (2015-2020)
12 Global Live Cell Imaging Market Size Forecast (2021-2025)
12.1 Global Live Cell Imaging Market Size Forecast (2021-2025)
12.2 Global Live Cell Imaging Market Forecast by Regions (2021-2025)
12.3 North America Live Cell Imaging Revenue Market Forecast (2021-2025)
12.4 Europe Live Cell Imaging Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Live Cell Imaging Revenue Market Forecast (2021-2025)
12.6 South America Live Cell Imaging Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Live Cell Imaging Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US

Tables and Figures

List of Tables

Table 1. Global Live Cell Imaging Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Live Cell Imaging by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Live Cell Imaging Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Live Cell Imaging Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Carl Zeiss (Germany) Corporate Information, Location and Competitors
Table 6. Carl Zeiss (Germany) Live Cell Imaging Major Business
Table 7. Carl Zeiss (Germany) Live Cell Imaging Total Revenue (USD Million) (2017-2018)
Table 8. Carl Zeiss (Germany) SWOT Analysis
Table 9. Carl Zeiss (Germany) Live Cell Imaging Product and Solutions
Table 10. Carl Zeiss (Germany) Live Cell Imaging Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Sigma-Aldrich (U.S.) Corporate Information, Location and Competitors
Table 12. Sigma-Aldrich (U.S.) Live Cell Imaging Major Business
Table 13. Sigma-Aldrich (U.S.) Live Cell Imaging Total Revenue (USD Million) (2018-2019)
Table 14. Sigma-Aldrich (U.S.) SWOT Analysis
Table 15. Sigma-Aldrich (U.S.) Live Cell Imaging Product and Solutions
Table 16. Sigma-Aldrich (U.S.) Live Cell Imaging Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. GE Healthcare (U.K.) Corporate Information, Location and Competitors
Table 18. GE Healthcare (U.K.) Live Cell Imaging Major Business
Table 19. GE Healthcare (U.K.) Live Cell Imaging Total Revenue (USD Million) (2017-2018)
Table 20. GE Healthcare (U.K.) SWOT Analysis
Table 21. GE Healthcare (U.K.) Live Cell Imaging Product and Solutions
Table 22. GE Healthcare (U.K.) Live Cell Imaging Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Leica Microsystems (Germany) Corporate Information, Location and Competitors
Table 24. Leica Microsystems (Germany) Live Cell Imaging Major Business
Table 25. Leica Microsystems (Germany) Live Cell Imaging Total Revenue (USD Million) (2017-2018)
Table 26. Leica Microsystems (Germany) SWOT Analysis
Table 27. Leica Microsystems (Germany) Live Cell Imaging Product and Solutions
Table 28. Leica Microsystems (Germany) Live Cell Imaging Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Danaher (U.S.) Corporate Information, Location and Competitors
Table 30. Danaher (U.S.) Live Cell Imaging Major Business
Table 31. Danaher (U.S.) Live Cell Imaging Total Revenue (USD Million) (2017-2018)
Table 32. Danaher (U.S.) SWOT Analysis
Table 33. Danaher (U.S.) Live Cell Imaging Product and Solutions
Table 34. Danaher (U.S.) Live Cell Imaging Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Olympus (Japan) Corporate Information, Location and Competitors
Table 36. Olympus (Japan) Live Cell Imaging Major Business
Table 37. Olympus (Japan) Live Cell Imaging Total Revenue (USD Million) (2017-2018)
Table 38. Olympus (Japan) SWOT Analysis
Table 39. Olympus (Japan) Live Cell Imaging Product and Solutions
Table 40. Olympus (Japan) Live Cell Imaging Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Molecular Devices (U.S.) Corporate Information, Location and Competitors
Table 42. Molecular Devices (U.S.) Live Cell Imaging Major Business
Table 43. Molecular Devices (U.S.) Live Cell Imaging Total Revenue (USD Million) (2017-2018)
Table 44. Molecular Devices (U.S.) SWOT Analysis
Table 45. Molecular Devices (U.S.) Live Cell Imaging Product and Solutions
Table 46. Molecular Devices (U.S.) Live Cell Imaging Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Thermo Fisher Scientific (U.S.) Corporate Information, Location and Competitors
Table 48. Thermo Fisher Scientific (U.S.) Live Cell Imaging Major Business
Table 49. Thermo Fisher Scientific (U.S.) Live Cell Imaging Total Revenue (USD Million) (2017-2018)
Table 50. Thermo Fisher Scientific (U.S.) SWOT Analysis
Table 51. Thermo Fisher Scientific (U.S.) Live Cell Imaging Product and Solutions
Table 52. Thermo Fisher Scientific (U.S.) Live Cell Imaging Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. BD (U.S.) Corporate Information, Location and Competitors
Table 54. BD (U.S.) Live Cell Imaging Major Business
Table 55. BD (U.S.) Live Cell Imaging Total Revenue (USD Million) (2017-2018)
Table 56. BD (U.S.) SWOT Analysis
Table 57. BD (U.S.) Live Cell Imaging Product and Solutions
Table 58. BD (U.S.) Live Cell Imaging Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. Nikon (Japan) Corporate Information, Location and Competitors
Table 60. Nikon (Japan) Live Cell Imaging Major Business
Table 61. Nikon (Japan) Live Cell Imaging Total Revenue (USD Million) (2017-2018)
Table 62. Nikon (Japan) SWOT Analysis
Table 63. Nikon (Japan) Live Cell Imaging Product and Solutions
Table 64. Nikon (Japan) Live Cell Imaging Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 65. PerkinElmer (U.S.) Corporate Information, Location and Competitors
Table 66. PerkinElmer (U.S.) Live Cell Imaging Major Business
Table 67. PerkinElmer (U.S.) Live Cell Imaging Total Revenue (USD Million) (2017-2018)
Table 68. PerkinElmer (U.S.) SWOT Analysis
Table 69. PerkinElmer (U.S.) Live Cell Imaging Product and Solutions
Table 70. PerkinElmer (U.S.) Live Cell Imaging Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 71. BioTek Instruments (U.S.) Corporate Information, Location and Competitors
Table 72. BioTek Instruments (U.S.) Live Cell Imaging Major Business
Table 73. BioTek Instruments (U.S.) Live Cell Imaging Total Revenue (USD Million) (2017-2018)
Table 74. BioTek Instruments (U.S.) SWOT Analysis
Table 75. BioTek Instruments (U.S.) Live Cell Imaging Product and Solutions
Table 76. BioTek Instruments (U.S.) Live Cell Imaging Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 77. Global Live Cell Imaging Revenue (Million USD) by Players (2015-2020)
Table 78. Global Live Cell Imaging Revenue Share by Players (2015-2020)
Table 79. Global Live Cell Imaging Revenue (Million USD) by Regions (2015-2020)
Table 80. Global Live Cell Imaging Revenue Market Share by Regions (2015-2020)
Table 81. North America Live Cell Imaging Revenue by Countries (2015-2020)
Table 82. North America Live Cell Imaging Revenue Market Share by Countries (2015-2020)
Table 83. Europe Live Cell Imaging Revenue (Million USD) by Countries (2015-2020)
Table 84. Asia-Pacific Live Cell Imaging Revenue (Million USD) by Countries (2015-2020)
Table 85. South America Live Cell Imaging Revenue by Countries (2015-2020)
Table 86. South America Live Cell Imaging Revenue Market Share by Countries (2015-2020)
Table 87. Middle East and Africa Live Cell Imaging Revenue (Million USD) by Countries (2015-2020)
Table 88. Middle East and Africa Live Cell Imaging Revenue Market Share by Countries (2015-2020)
Table 89. Global Live Cell Imaging Revenue (Million USD) by Type (2015-2020)
Table 90. Global Live Cell Imaging Revenue Share by Type (2015-2020)
Table 91. Global Live Cell Imaging Revenue Forecast by Type (2021-2025)
Table 92. Global Live Cell Imaging Revenue by Application (2015-2020)
Table 93. Global Live Cell Imaging Revenue Share by Application (2015-2020)
Table 94. Global Live Cell Imaging Revenue Forecast by Application (2021-2025)
Table 95. Global Live Cell Imaging Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Live Cell Imaging Picture
Figure 2. Global Live Cell Imaging Revenue Market Share by Type in 2019
Figure 3. Equipment Picture
Figure 4. Consumables Picture
Figure 5. Software Picture
Figure 6. Live Cell Imaging Revenue Market Share by Application in 2019
Figure 7. Hospitals Picture
Figure 8. Pharmaceutical Companies Picture
Figure 9. Biotechnological Companies Picture
Figure 10. Diagnostic Laboratories Picture
Figure 11. Others Picture
Figure 12. Global Live Cell Imaging Revenue (USD Million) and Growth Rate (2015-2025)
Figure 13. North America Live Cell Imaging Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Europe Live Cell Imaging Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Asia-Pacific Live Cell Imaging Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. South America Live Cell Imaging Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Middle East and Africa Live Cell Imaging Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Global Live Cell Imaging Revenue (Million USD) and Growth Rate (2015-2025)
Figure 19. Global Live Cell Imaging Revenue Share by Players in 2019
Figure 20. Global Top 5 Players Live Cell Imaging Revenue Market Share in 2019
Figure 21. Global Top 10 Players Live Cell Imaging Revenue Market Share in 2019
Figure 22. Key Players Market Share Trend
Figure 23. Global Live Cell Imaging Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 24. Global Live Cell Imaging Revenue Market Share by Regions (2015-2020)
Figure 25. Global Live Cell Imaging Revenue Market Share by Regions in 2018
Figure 26. North America Live Cell Imaging Revenue and Growth Rate (2015-2020)
Figure 27. Europe Live Cell Imaging Revenue and Growth Rate (2015-2020)
Figure 28. Asia-Pacific Live Cell Imaging Revenue and Growth Rate (2015-2020)
Figure 29. South America Live Cell Imaging Revenue and Growth Rate (2015-2020)
Figure 30. Middle East and Africa Live Cell Imaging Revenue and Growth Rate (2015-2020)
Figure 31. North America Live Cell Imaging Revenue Market Share by Countries (2015-2020)
Figure 32. North America Live Cell Imaging Revenue Market Share by Countries in 2019
Figure 33. USA Live Cell Imaging Revenue and Growth Rate (2015-2020)
Figure 34. Canada Live Cell Imaging Revenue and Growth Rate (2015-2020)
Figure 35. Mexico Live Cell Imaging Revenue and Growth Rate (2015-2020)
Figure 36. Europe Live Cell Imaging Revenue Market Share by Countries (2015-2020)
Figure 37. Europe Live Cell Imaging Revenue Market Share by Countries in 2019
Figure 38. Germany Live Cell Imaging Revenue and Growth Rate (2015-2020)
Figure 39. UK Live Cell Imaging Revenue and Growth Rate (2015-2020)
Figure 40. France Live Cell Imaging Revenue and Growth Rate (2015-2020)
Figure 41. Russia Live Cell Imaging Revenue and Growth Rate (2015-2020)
Figure 42. Italy Live Cell Imaging Revenue and Growth Rate (2015-2020)
Figure 43. Asia-Pacific Live Cell Imaging Revenue Market Share by Countries (2015-2020)
Figure 44. Asia-Pacific Live Cell Imaging Revenue Market Share by Countries in 2019
Figure 45. China Live Cell Imaging Revenue and Growth Rate (2015-2020)
Figure 46. Japan Live Cell Imaging Revenue and Growth Rate (2015-2020)
Figure 47. Korea Live Cell Imaging Revenue and Growth Rate (2015-2020)
Figure 48. India Live Cell Imaging Revenue and Growth Rate (2015-2020)
Figure 49. Southeast Asia Live Cell Imaging Revenue and Growth Rate (2015-2020)
Figure 50. South America Live Cell Imaging Revenue Market Share by Countries (2015-2020)
Figure 51. South America Live Cell Imaging Revenue Market Share by Countries in 2019
Figure 52. Brazil Live Cell Imaging Revenue and Growth Rate (2015-2020)
Figure 53. Argentina Live Cell Imaging Revenue and Growth Rate (2015-2020)
Figure 54. Middle East and Africa Live Cell Imaging Revenue Market Share by Countries (2015-2020)
Figure 55. Middle East and Africa Live Cell Imaging Revenue Market Share by Countries in 2019
Figure 56. Saudi Arabia Live Cell Imaging Revenue and Growth Rate (2015-2020)
Figure 57. UAE Live Cell Imaging Revenue and Growth Rate (2015-2020)
Figure 58. Egypt Live Cell Imaging Revenue and Growth Rate (2015-2020)
Figure 59. South Africa Live Cell Imaging Revenue and Growth Rate (2015-2020)
Figure 60. Global Live Cell Imaging Revenue Share by Type (2015-2020)
Figure 61. Global Live Cell Imaging Revenue Share by Type in 2019
Figure 62. Global Live Cell Imaging Market Share Forecast by Type (2021-2025)
Figure 63. Global Equipment Revenue Growth Rate (2015-2020)
Figure 64. Global Consumables Revenue Growth Rate (2015-2020)
Figure 65. Global Software Revenue Growth Rate (2015-2020)
Figure 66. Global Live Cell Imaging Revenue Share by Application (2015-2020)
Figure 67. Global Live Cell Imaging Revenue Share by Application in 2019
Figure 68. Global Live Cell Imaging Market Share Forecast by Application (2021-2025)
Figure 69. Global Hospitals Revenue Growth Rate (2015-2020)
Figure 70. Global Pharmaceutical Companies Revenue Growth Rate (2015-2020)
Figure 71. Global Biotechnological Companies Revenue Growth Rate (2015-2020)
Figure 72. Global Diagnostic Laboratories Revenue Growth Rate (2015-2020)
Figure 73. Global Others Revenue Growth Rate (2015-2020)
Figure 74. Global Live Cell Imaging Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 75. Global Live Cell Imaging Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 76. Global Live Cell Imaging Revenue Market Share Forecast by Regions (2021-2025)
Figure 77. North America Live Cell Imaging Revenue Market Forecast (2021-2025)
Figure 78. Europe Live Cell Imaging Revenue Market Forecast (2021-2025)
Figure 79. Asia-Pacific Live Cell Imaging Revenue Market Forecast (2021-2025)
Figure 80. South America Live Cell Imaging Revenue Market Forecast (2021-2025)
Figure 81. Middle East and Africa Live Cell Imaging Revenue Market Forecast (2021-2025)
Figure 82. Sales Channel: Direct Channel vs Indirect Channel




Companies Mentioned
Carl Zeiss (Germany)
Sigma-Aldrich (U.S.)
GE Healthcare (U.K.)
Leica Microsystems (Germany)
Danaher (U.S.)
Olympus (Japan)
Molecular Devices (U.S.)
Thermo Fisher Scientific (U.S.)
BD (U.S.)
Nikon (Japan)
PerkinElmer (U.S.)
BioTek Instruments (U.S.)

Reason to Buy

  • Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The segment that is expected to dominate the Pharma & Healthcare Market
  • Regions that are expected to witness the fastest growth during the forecast period
  • Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets